Evaluation of myofibroblasts in oral submucous fibrosis: Correlation with disease severity

Journal of Oral Pathology and Medicine

Volumn 40, Issue 3, 2011, Pages 208-213

  Angadi, Punnya V ^a   Kale, Alka D ^a   Hallikerimath, Seema ^a  

^a KLE VK INSTITUTE OF DENTAL SCIENCES   (India)

Author keywords

Areca nut; Fibrosis; Histological stages; Myofibroblasts; Oral submucous fibrosis; Pathogenesis; Wound healing

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN;

ARTICLE; CELL DIFFERENTIATION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH DISEASE; MOUTH MUCOSA; MYOFIBROBLAST; PRIORITY JOURNAL;

ACTINS; BIOLOGICAL MARKERS; CELL COUNT; CELL DIFFERENTIATION; CONNECTIVE TISSUE; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; MYOFIBROBLASTS; ORAL SUBMUCOUS FIBROSIS;

EID: 79951875844     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00995.x     Document Type: Article

References (35)

1. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakuasuriya S. Oral Submucous fibrosis: review on etiology and pathogenesis. Oral Oncol 2006; 42: 561-8.
2. Pindborg JJ, Sirasat SM. Oral Submucous fibrosis. Oral Surg, Oral Med, Oral Pathol 1966; 22: 764-9.
3. Bishen KA, Radhakrishnan R, Satyamoorthy K. The role of basic fibroblast growth factor in oral submucous fibrosis. J Oral Pathol Med 2008; 37: 402-11.
4. Yanjia H, Xinchun J. The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis. Clinica Chemica Acta 2007; 383: 51-6.
5. Rajalalitha P, Vali S. Molecular pathogenesis of oral submucous fibrosis- a collagen metabolic disorder. J Oral Pathol Med 2005; 34: 321-8.
6. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003; 200: 500-3.
7. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts, I: paracrine cells in health and disease. Am J Physiol 1999; 277: C1-9.
8. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol 2002; 3: 349-63.
9. Watsky MA, Weber KT, Sun Y, Postlethwaite A. New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies. Int Rev Cell Mol Biol 2010; 282: 165-92.
10. Phan SH. Biology of fibroblasts and myofibroblasts. Proc Am Thorac Soc. 2008; 5: 334-7.
11. Hinz B, Phan SH, Thannickal VJ, et al. The myofibroblast: one function, multiple origins. Am J Pathol 2007; 170: 1087-816.
12. Etemad-Moghadam S, Khalili M, Tirgary F, Alaeddin M. Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol 2009; 38: 625-43.
13. Wynn TA. Cellular and Molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210.
14. Wallach-Dayan SB, Golan-Gersti R, Breuer R. Evasion of myofibroblasts from immune surveillance: a mechanism for tissue fibrosis. PNAS 2007; 104: 20460-5.
15. Kissin EY, Merkel PA, Lafyatis R. Myofibroblasts and hyalinised collagen as markers of skin disease in systemic sclerosis. Arthritis Rheum 2006; 54: 3655-60.
16. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during transition from granulation tissue to scar. Am J Pathol 1995; 146: 56-66.
17. Utsunomiya h, Tilakaratne WM, Oshiro K, et al. Extracellular matrix remodeling in oral Submucous fibrosis: its stage specific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med 2005; 34: 498-507.
18. Dabelsteen S, Christensen S, Gron B, Bardow A, Dabelsteen E. HGF is released from buccal fibroblasts after smokeless tobacco stimulation. Oral Oncol 2005; 41: 509-14.
19. Phan SH. Biology of fibroblasts and myofibroblasts. Proc Am Thorac Soc. 2008; 5: 334-7.
20. Hinz B. The myofibroblast: paradigm for a mechanically active cell. J Biomech 2010; 43: 146-55.
21. Shephard P, Martin F, Smola-Hess S, et al. Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous TGF-β and IL-1. Am J Pathol 2004; 164: 2055-66.
22. Jelaska A, Korn JH. Role of apoptosis and transforming growth factor β1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum 2000; 43: 2230-9.
23. Moutasim KA, Mirza D, Marsh D, et al. Integrin αvβ6 promotes TGF-β1 dependent myofibroblastic transdifferentiation in oral submucous fibrosis. Head & Neck Oncol 2009; 1(Suppl 1): 14.
24. Leask A. Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment. Fibrogenesis and tissue repair 2010; 3: 8.
25. Phan SH. The myofibroblast in pulmonary fibrosis. Chest 2010; 122: 286-9.
26. Li X, Ling TY, Gao YJ. Effect of arecoline on the differentiation of myofibroblasts of oral mucosa (Abstract). Zhongua Kuo Qiang Yi Xue Za Zhi 2007; 42: 423-7.
27. Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta Pc, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17year period. Community Dent Oral Epidemiol 1985; 13: 340-1.
28. Desmouliere A, Guyot C, Gabbianai G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 2004; 48: 509-17.
29. Xouri G, Christian S. Origin and function of tumor stroma fibroblasts. Semin Cell Dev Biol 2010; 21: 40-6.
30. Radisky DC, Kenny PA, Bissell MJ. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J Cell Biochem 2007; 101: 830-9.
31. Hu M, Peluffo G, Chen H, Gelman R, Schnitt S, Polyak K. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proc Natl Acad Sci USA 2009; 106: 3372-7.
32. Daniels CE, Jett RR. Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 2005; 11: 431-7.
33. Bissell DM. Chronic liver injury, TGF-beta, and cancer. Exp Mol Med 2001; 33: 179-90.
34. Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 2000; 60: 2562-6.
35. Lalli A, Tilakaratne WM, Ariyawardana A, et al. An altered keratinocyte phenotype in oral submucous fibrosis: correlation of keratin K17 expression with disease severity. J Oral Pathol Med 2008; 37: 211-20.